跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Auromide Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Auromide Plus
Approved
STANDARD
Auromide Plus
Aurolab
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e2d29c9bce32f76b
Company
Aurolab
Type
Standard
Approval Details
Approval Id
e2d29c9bce32f76b
Drug Approval Philippines Name
Auromide Plus
Product Name
Auromide Plus
Registration Number
DRP-4021
Brand Name
Auromide Plus
Generic Name
Tropicamide + Phenylephrine Hydrochloride
Dosage Form
Ophthalmic Solution
Dosage Strength
8mg/mL (0.8 W/V) / 50mg/mL (5%W/V)
Manufacturer
Aurolab
Importer
Brady Pharma Inc.
Distributor
Brady Pharma Inc.
Company Detail Path
/organization/aurolab-trust
Issuance Date
28 February 2023
Expiry Date
04 June 2028
Pharmacologic Category
Anticholinergic/ Adrenergic Agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e2d29c9bce32f76b
Type
Standard
Back to Philippines FDA Approvals